Government puts foot down on Pfizer, Moderna jabs

The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 83 crore.

Published: 22nd September 2021 10:00 PM  |   Last Updated: 23rd September 2021 08:04 AM   |  A+A-

Global pharma major Pfizer

Global pharma major Pfizer (Photo | AP)

Express News Service

NEW DELHI:  Buoyed by the improved supply of Covid-19 vaccines in India over the last few weeks, the Centre has decided to put on hold the ongoing negotiations with Pfizer and Moderna to import their vaccines. The talks have been stuck over demand of indemnity by these firms. 

The government has not been agreeing to the demand of the US companies for legal protection in case of any side-effects from the use of their vaccines despite having been in a negotiation with them since May.

Health ministry officials said the government sees no point in going ahead with the talks as supply from local vaccine makers had “considerably improved and will get better in the coming months”. The government has put its foot down as no company has received such protection in India so far, said a source.

In India, 83 lakh vaccine doses have been administered so far. Over the last one month, nearly 75 lakh shots are being administered on a daily basis. For September, the government has projected the availability of nearly 20-22 crore doses while in October, this figure is expected to reach about 30 crore-mark. “From October, the daily vaccinations could go up to 1.2-1.3 crore every day,” N K Arora, head of the Covid-19 working group of National Technical Advisory Group Immunisation had earlier told this newspaper. This was without taking into account vaccines by Pfizer and Moderna, he added.

A note prepared by the Centre last month had projected the production of nearly 78 crore doses of Covishield and Covaxin between September-November. Government sources said vaccines by Zydus Cadila, Biological E, Covovax and Gennova will also be available from October. “We are hoping to get 35-40 crore doses in the next three months which will take the total tally to nearly 200 crore doses by the year-end,” said a source. 


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp